Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 2—February 2005


Malaria Epidemic and Drug Resistance, Djibouti

Christophe Rogier*Comments to Author , Bruno Pradines*, H. Bogreau*, Jean-Louis Koeck†‡, Mohamed-Ali Kamil§, and Odile Mercereau-Puijalon¶
Author affiliations: *IMTSSA-IFR48, Marseille, France; †Centre Hospitalier des Armées Bouffard, Djibouti; ‡HIA Val de Grace, Paris, France; §Ministry of Health, Djibouti; ¶Institut Pasteur, Paris, France

Main Article

Table 3

In vitro drug sensitivity of 27 Plasmodium falciparum isolates collected in Djibouti, 1999

Drugs Isolates studied (n) Mean IC50* 95% confidence interval Cut-off value % resistant isolates
Chloroquine 27 326 nmol/L 224–474 nmol/L >100 nmol/L 93
Amodiaquine 27 10.0 nmol/L 8.0–12.6 nmol/L >80 nmol/L 0
Cycloguanil 24 13 nmol/L 8–21 nmol/L >500 nmol/L 4
Pyrimethamine 25 69 nmol/L 41–117 nmol/L >2,000 nmol/L 4

*The 50% inhibitory concentration (IC50) of chloroquine diphosphate, amodiaquine, pyrimethamine dihydrochloride, and cycloguanil, i.e., the drug concentration corresponding to 50% of the uptake of 3H-hypoxanthine by the parasites in drug-free control wells, was determined by nonlinear regression analysis of log-dose/response curves. Mean IC50 and proportion of resistant isolates according to cut-off values are indicated. Data were expressed as the geometric mean IC50 and 95% confidence intervals were calculated.

Main Article